The Novor Team is heading to San Diego to attend the largest, most influential biotech Convention, BIO 2017, June 19-22, 2017.

We are excited to show case our ground breaking antibody protein sequencing technology at booth #5227, in the Discovery Zone, in Hall G.

Different from the traditional DNA sequencing technology, we directly sequence the antibody protein using mass spectrometry, without the need to access the cell line. We only require 200ug monoclonal antibody protein sample, with purity > 95%, you will get the sequences that work in just a few weeks.

If you engage in activities related to antibody generation, discovery, characterization or engineering, we invite you for a chat and see how we may help.

BIO, here we come!

Sign up for the newsletter.

Sign up for the next webinar.

Whitepaper: Prevalence of Secondary Light Chains

Talk to Our Scientists.

We Have Sequenced 3000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.

Talk to Our Scientists.

We Have Sequenced 3000+ Antibodies and We Are Eager to Help You.

Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics

Talk to our scientists. We have sequenced over 3000 antibodies and we are eager to help you.